Every trader knows that the right information at the right time can provide a decisive edge. In today’s highly digitised markets, data scarcity is no longer the issue. The real challenge lies in separating meaningful signals from noise. Nowhere is that challenge more acute than in OTC market data.
Unlike exchange traded markets, OTC markets operate with limited transparency, fragmented liquidity, and bespoke instruments. For firms that rely on accurate pricing, valuation, and risk assessment, low quality or biased data can materially distort decision making.
In this article, Arpita Nigam, Head of Capital Markets Data Solutions at Parameta Solutions, explore what makes OTC markets unique, why high fidelity data matters, and how specialised OTC market data providers can deliver critical insight for pricing, alpha generation, and risk mitigation.
What Are OTC Markets?
Over-the-counter (OTC) markets are decentralised markets where financial instruments are traded directly between counterparties rather than on an exchange. These instruments include derivatives, bonds, and commodities, spanning asset classes such as fixed income, interest rates, credit, equity derivatives, energy, and commodities.
While not all market participants trade OTC instruments directly, OTC activity has a significant influence on listed markets. Large block trades executed off exchange can materially impact screen prices, valuations, and risk metrics.
To put the scale into perspective: while global equity markets total approximately $154 trillion, OTC markets account for around $846 trillion in notional traded1—more than four times larger.
A useful analogy is an iceberg. Exchange traded markets represent the visible tip, while OTC markets form the vast mass beneath the surface. Firms that rely only on exchange data see only part of the picture—and risk missing the signals that truly move markets.
Why OTC Market Data Is So Challenging
OTC markets are not only vast but inherently complex. They are characterised by:
- Fragmented liquidity
Trading occurs bilaterally rather than on centralised venues, making it difficult to construct accurate curves, volatility surfaces, or consensus prices.
- Custom instruments
OTC markets support a wide range of bespoke structures, tenors, and contract terms, reflecting diverse trading strategies and hedging needs.
- Complex workflows
Firms trading OTC derivatives for portfolio protection, speculation, or asset allocation rely heavily on quantitative and systematic analysis. Without robust, highquality pricing data, assessing fair value and meeting transparency requirements becomes increasingly difficult.
As regulatory scrutiny grows, so does the need for data that is not only available—but reliable, consistent, and defensible.
Why Independence Matters in OTC Market Data
In OTC markets, small pricing discrepancies can translate into significant risk exposure. That makes independent data essential.
Independent OTC market data provides:
- Fair valuation benchmarks for portfolio management and regulatory reporting
- Confidence in execution, supporting accurate price discovery
- Enhanced risk management, enabling firms to identify liquidity conditions and volatility trends
Data independence means pricing is free from conflicts of interest and grounded in actual market activity—not derived estimates or thinly traded proxies.
How Market Firms Use High Fidelity OTC Data
OTC market data must be structured, enriched, and usable across the front, middle, and back office. Asset managers, banks, and institutional investors rely on it across the full trade lifecycle.
Pre-Trade: Research and Price Discovery
For firms entering a new market or asset class, quantitative research teams assess whether alpha generating strategies are viable. Historical and timeseries OTC data allows analysis from a true trading perspective.
Realtime data supports price discovery across FX, interest rates, and commodities. For example, Parameta’s real-time oil price offering enables firms to monitor intraday pricing, identify entry and exit points, and assess market dynamics as they unfold.
Post-Trade: Risk, Compliance, and Performance
Once a strategy is live, firms require ongoing data to manage risk and meet compliance obligations. Indicative pricing, transactional data, and indices all support this process.
More advanced workflows combine proprietary trade data with Parameta pricing to perform transaction cost analysis (TCA), liquidity assessment, and price-volume analytics. These insights help explain execution performance, market microstructure behaviour, and risk characteristics across OTC markets.
OTC markets data from Parameta Solutions
High quality OTC market data is defined by how accurately it reflects real trading conditions, and Parameta’s data is grounded in the wholesale interdealer activity that underpins global OTC markets. By drawing on pricing derived from actual market transactions, Parameta offers:
- High quality OTC market data, indices and analytics across interest rate swaps and options, money markets, FX, and energy and commodities
- Data from the world’s largest inter-dealer broker, TP ICAP
- Coverage across 200+ asset classes
- Accurate real world data sets
- Independent and unconflicted data
- Seamless and secure data delivery direct, via cloud or third-party distributor
- Strong data governance
For more information on our derivative data solutions, please contact us to discuss your requirements or see a data sample.
Bibliography
Bibliography
https://www.bis.org/publ/otc_hy2512.htm#:~:text=The%20notional%20value%20of%20outstanding,(yoy)%20to%20%2421.8%20trillion
Read SourceDisclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
